Rothman Paul bought MRK
May 29, 2026 · Form 4 insider transaction
Rothman Paul bought 1,853.1 shares of Merck & Co., Inc. at $118.72 per share, a transaction worth $220.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,853.1
Price
$118.72
Total value
$220.0K
InsiderRothman Paul
Role—
CompanyMerck & Co., Inc. (MRK)
SecurityPhantom Stock
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after34,945
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1-for-1; Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.; Holdings include shares acquired in dividend reinvestment transactions.